Biomarkers in Oncology
Preț: 399,00 lei
Disponibilitate: în stoc la furnizor
Autor: Lenz, Heinz-Josef (Ed.)
ISBN: 978-1-4614-8315-1
Editura: Springer Nature
Anul publicarii: 2013
Pagini: 447
Categoria: ONCOLOGY
DESCRIERE
Essential resource for clinical use and cancer research
A powerful tool that covers the entire spectrum of cancer biomarkers in development and clinical use
Explores predictive and prognostic markers
Written by international experts
Provides insight into toxicity and surrogate markers
This integrated book covers the entire spectrum of cancer biomarkers in development and clinical use. Predictive and prognostic markers are explored in the context of colon cancer, breast cancer, lung cancer, prostate cancer, and GIST. International experts provide insight into toxicity markers and surrogate markers. Attention is also given to biomarker assay development, validation, and strategies.
A powerful tool for determining decisions on therapy, selecting drug regimens, monitoring the efficacy of treatment, and performing individualized surveillance, biomarkers represent the forefront of cancer research and treatment. As these technologies become increasingly available for clinical use, this book will be an essential resource for oncologists and translational researchers.
A powerful tool that covers the entire spectrum of cancer biomarkers in development and clinical use
Explores predictive and prognostic markers
Written by international experts
Provides insight into toxicity and surrogate markers
This integrated book covers the entire spectrum of cancer biomarkers in development and clinical use. Predictive and prognostic markers are explored in the context of colon cancer, breast cancer, lung cancer, prostate cancer, and GIST. International experts provide insight into toxicity markers and surrogate markers. Attention is also given to biomarker assay development, validation, and strategies.
A powerful tool for determining decisions on therapy, selecting drug regimens, monitoring the efficacy of treatment, and performing individualized surveillance, biomarkers represent the forefront of cancer research and treatment. As these technologies become increasingly available for clinical use, this book will be an essential resource for oncologists and translational researchers.
Categorii de carte
-Comandă specială
-Edituri
-Promo
-Publicaţii Callisto
-Cărţi noi
-- 1155,00 leiPRP: 1260,00 lei
- 1365,00 leiPRP: 1575,00 lei
- 1890,00 lei
Promoţii
-- 1155,00 leiPRP: 1260,00 lei
- 1365,00 leiPRP: 1575,00 lei
- 1428,00 leiPRP: 1680,00 lei
REVIEW-URI